Omalizumab management beyond clinical trials: The added value of a network model
Conclusion Our retrospective analysis represents a preliminary report from the NEONet activity. It confirmed omalizumab efficacy and provided some new insights about its impact on lung function and on comorbid rhinitis. The network approach, under a prospective view, allows creating a large uniform database, by means of a standardized shared tool for data collecting, and joining a multidisciplinary expertise.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Clinical Trials | Databases & Libraries | Drugs & Pharmacology | Environmental Health | Respiratory Medicine | Statistics | Study | Xolair